ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
NEUROTECH INTERNATIONAL LTD
0.012
-0.001
-7.69%
成交量:
445.90萬
成交額:
5.75萬
市值:
1,939.28萬
市盈率:
-3.28
高:
0.014
開:
0.014
低:
0.012
收:
0.013
52周最高:
0.029
52周最低:
0.010
股本:
16.16億
流通股本:
7.68億
量比:
4.83
換手率:
0.58%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.004
每股收益(LYR):
-0.010
淨資產收益率:
-66.30%
總資產收益率:
-37.64%
市淨率:
3.30
市盈率(LYR):
-1.17
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Neurotech International 獲約450萬澳元定向增資承諾,發行價每股0.014澳元
投资观察
·
08/04
Neurotech International 完成約450萬澳元股份配售,每股定價0.014澳元
美股速递
·
08/04
Neurotech International宣佈美國FDA已批准NTI164的IND申請
投资观察
·
07/14
分析-2025年,隨着高價基因療法上市數量減少,美國新藥價格出現下降
路透中文
·
06/25
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/NTI.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NTI.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NTI.AU\",,,,,undefined,":{"symbol":"NTI.AU","market":"AU","secType":"STK","nameCN":"NEUROTECH INTERNATIONAL LTD","latestPrice":0.012,"timestamp":1787638320000,"preClose":0.013,"halted":0,"volume":4458951,"delay":0,"changeRate":-0.07692307692307686,"nameEN":"NEUROTECH INTERNATIONAL LTD","floatShares":768083617,"shares":1616069964,"eps":-0.003661,"marketStatus":"未開盤","change":-0.001,"latestTime":"08-25 16:12:00 AEST","open":0.014,"high":0.014,"low":0.012,"amount":57528,"amplitude":0.153846,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.003661,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.013,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":4.8307569739459755,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NTI.AU","preClose":0.012,"auctionPrice":0.013,"auctionVolume":320948,"auctionTime":1787692807463,"referenceTime":1787653803093,"auction":1,"marketStatus":"盘前竞价","timestamp":1787692807463}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NTI.AU\",,,,,undefined,":{"symbol":"NTI.AU","floatShares":768083617,"roa":"-37.64%","roe":"-66.30%","lyrEps":-0.010231,"volumeRatio":4.8307569739459755,"shares":1616069964,"dividePrice":0,"high":0.014,"amplitude":0.153846,"preClose":0.013,"low":0.012,"week52Low":0.01,"pbRate":"3.30","psRate":"2.74","week52High":0.029,"institutionHeld":0,"latestPrice":0.012,"eps":-0.003661,"divideRate":0,"volume":4458951,"delay":0,"ttmEps":-0.003661,"open":0.014,"prevYearClose":0.014,"prevWeekClose":0.014,"prevMonthClose":0.016,"prevQuarterClose":0.014,"fiveDayClose":0.014,"twentyDayClose":0.017,"sixtyDayClose":0.012,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTI.AU\",params:#limit:5,,,undefined,":[{"date":"2023-10-27","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1698361200000,"name":null,"time":"","dateTimestamp":1698325200000,"actualEps":null},{"date":"2023-07-26","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1690329600000,"name":null,"time":"","dateTimestamp":1690293600000,"actualEps":null},{"market":"AU","date":"2023-04-27","symbol":"NTI.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1682517600000,"reportTimeType":"","actualEps":null},{"date":"2023-01-30","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1675033200000,"name":null,"time":"","dateTimestamp":1674997200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTI.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTI.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1168763117","title":"Neurotech International 獲約450萬澳元定向增資承諾,發行價每股0.014澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168763117","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168763117?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 09:55","pubTimestamp":1785808538,"startTime":"0","endTime":"0","summary":"Neurotech International Ltd(代码:NTI.AX)宣布,已获得总额约450万澳元的定向增资承诺。此次配售的价格设定为每股0.014澳元。这一消息于8月4日对外公布,标志着公司资本运作迈出关键一步。相关细节已在随后的公司公告中进一步披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","NTI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120903726","title":"Neurotech International 完成約450萬澳元股份配售,每股定價0.014澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120903726","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120903726?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 07:29","pubTimestamp":1785799763,"startTime":"0","endTime":"0","summary":"Neurotech International 已获得具有约束力的认购承诺,将通过股份配售募集约450万澳元。此次配售的定价为每股0.014澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","NTI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101553097","title":"Neurotech International宣佈美國FDA已批准NTI164的IND申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1101553097","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101553097?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 09:56","pubTimestamp":1783994192,"startTime":"0","endTime":"0","summary":"Neurotech International Ltd 宣布,其新药NTI164的试验性新药申请已获得美国食品药品监督管理局的批准。\n这一监管进展为该公司推进其候选药物的临床开发计划铺平了道路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","NTI.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646794508","title":"分析-2025年,隨着高價基因療法上市數量減少,美國新藥價格出現下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2646794508","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646794508?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 18:01","pubTimestamp":1782381707,"startTime":"0","endTime":"0","summary":"分析-2025年,随着高价基因疗法上市数量减少,美国新药价格出现下降2025年获FDA批准的药品年均标价中位数为216,000美元2025年,FDA批准了51种新药,其中包括5种细胞和基因疗法2025年获批药物中,小分子药物占比超过67%,高于2024年的62%Deena Beasley路透6月25日-一项最新分析显示,2025年美国监管机构批准的处方药上市价格虽较上年有所下降,但受罕见病高价药物影响,中位数仍高达216,000美元。基因疗法通常只需给药一次,其价格可能高达数百万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nL4S42X0VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4532","JAZZ","IE00BN0W2W23.USD","LU0320765992.SGD","BK4007","BK4533","ABEO","BK4548","LU0154245756.USD","LU0882574055.USD","BK7508","LU0823416689.USD","BK4585","CSL.AU","LU0114720955.EUR","LU0154245673.USD","BK7007","BK4139","BK7501","BK4539","BK7067","IONS","BK4588","LU0109394709.USD","LENZ","IE00BN0W2T93.GBP","BK7511","NTI.AU","IE00BN0W2V16.EUR","ALNY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NTI.AU\",params:#limit:6,delay:true,,,undefined,":[]}}